RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Operative Vaginal Reconstruction Pain
2018年7月19日 更新者:TriHealth Inc.
The Effect of Intravenous Acetaminophen on Post-operative Pain and Narcotic Consumption in Vaginal Reconstructive Surgery Patients: A Randomized Controlled Trial
This randomized controlled trial will evaluate the effects of perioperative intravenous (IV) acetaminophen on postoperative narcotic consumption and pain scores in subjects undergoing vaginal reconstructive surgery.
One hundred subjects will be randomly assigned to receive either IV acetaminophen or IV placebo.
Those in the IV acetaminophen group will receive 1000mg IV every 6 hours for 24 hours beginning prior to anesthesia induction.
The control group will receive placebo saline infusions at the same time intervals.
All subjects will receive as needed (prn) IV narcotic for additional pain relief.
Visual analog scales (VAS) regarding pain will be evaluated at 18 and 24 hours postoperative and immediately prior to discharge.
We will also collect total IV narcotic consumption.
We hypothesize that subjects receiving IV acetaminophen will have lower VAS scores and decreased total narcotic consumption in comparison to the control group.
研究概览
详细说明
see brief summary
研究类型
介入性
注册 (实际的)
100
阶段
- 第四阶段
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
Ohio
-
Cincinnati、Ohio、美国、45220
- TriHealth - Good Samaritan and Bethesda North Hospitals
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 至 70年 (成人、年长者)
接受健康志愿者
不
有资格学习的性别
女性
描述
Inclusion Criteria:
- Women between the ages of 18 and 70 years
- Patients of the Division of Urogynecology at Good Samaritan and Bethesda North Hospitals in Cincinnati, Ohio
- Scheduled to undergo major vaginal reconstruction
- Must undergo total vaginal hysterectomy, anterior repair, posterior repair, enterocele repair, and intraperitoneal vault suspension. The addition of suburethral sling is not a cause for exclusion.
Exclusion Criteria:
- Allergy to acetaminophen
- Liver disease (chronic or active)
- Chronic alcohol use (>1 drink/day)
- Bleeding diathesis
- Renal disease
- Opiate dependent or daily use
- History of chronic pain
- Mental or cognitive disorder preventing patient to accurately verbalize pain levels
- Undergoing abdominal or laparoscopic procedures at the time of surgery
- Allergy to hydromorphone
- Surgery is not performed under general anesthesia
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:支持治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:三倍
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:IV Acetaminophen
Subjects will receive a 1000mg dose of IV acetaminophen in 100mL solution every 6 hours for 24 hours.
The first dose will be administered prior to anesthesia induction, approximately 30 minutes before skin incision.
A total of 4 doses will be given.
|
Details covered in arm description.
其他名称:
|
|
安慰剂比较:Saline
Subjects will receive a 100mL dose of IV saline every 6 hours for 24 hours.
The first dose will be administered prior to anesthesia induction, approximately 30 minutes before skin incision.
A total of 4 doses will be given.
|
Details covered in arm description.
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Pain While Active - 18 hr
大体时间:18 hours
|
Post operative pain will be assessed 18 hours after surgery.
Pain will be self reported by patients using a 0-100 mm visual analog scale (VAS) with 0 indicating no pain and 100 indicating the worst pain imaginable.
A pain score will be collected for pain while active.
|
18 hours
|
|
Total Amount of Narcotic Consumption in the First 24 Hours Post Surgery
大体时间:24 hours
|
Hydromorphone will be administered for breakthrough pain.
The total amount consumed in the first 24 hours post surgery will be recorded.
|
24 hours
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Narcotic Associated Side Effects
大体时间:24 hours
|
The incidence of known narcotic associated side effects will be recorded for nausea/vomiting.
|
24 hours
|
|
Time to First Rescue Narcotic
大体时间:24 hours
|
The time from the end of surgery to the time any IV narcotic is given.
|
24 hours
|
|
Narcotic Associated Side Effects
大体时间:24 hours
|
The incidence of known narcotic associated side effects will be recorded for itching.
|
24 hours
|
|
Narcotic Associated Side Effects
大体时间:24 hours
|
The incidence of known narcotic associated side effects will be recorded for headache.
|
24 hours
|
|
Narcotic Associated Side Effects
大体时间:24 hours
|
The incidence of known narcotic associated side effects will be recorded for insomnia.
|
24 hours
|
|
Narcotic Associated Side Effects
大体时间:24 hours
|
The incidence of known narcotic associated side effects will be recorded for rash/hives.
|
24 hours
|
|
Narcotic Associated Side Effects
大体时间:24 hours
|
The incidence of known narcotic associated side effects will be recorded for shortness of breath.
|
24 hours
|
|
Narcotic Associated Side Effects
大体时间:24 hours
|
The incidence of known narcotic associated side effects will be recorded for respiratory depression.
|
24 hours
|
|
Narcotic Associated Side Effects
大体时间:24 hours
|
The incidence of known narcotic associated side effects will be recorded for urinary retention.
|
24 hours
|
|
Time to Ambulation
大体时间:1800 minutes
|
Length of time from the end of surgery to the time of ambulation.
|
1800 minutes
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Time to First Flatus/Bowel Movement
大体时间:9000 minutes
|
Length of time from the end of surgery to the time of first flatus or bowel movement.
|
9000 minutes
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始
2014年1月1日
初级完成 (实际的)
2016年8月1日
研究完成 (实际的)
2016年8月1日
研究注册日期
首次提交
2014年1月21日
首先提交符合 QC 标准的
2014年1月21日
首次发布 (估计)
2014年1月23日
研究记录更新
最后更新发布 (实际的)
2018年8月16日
上次提交的符合 QC 标准的更新
2018年7月19日
最后验证
2018年2月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.